January 13, 2026

Restoring missing lipid may help ease dementia damage in brain, study finds

January 13, 2026 / Research update / InnovateMed Author / lipid

Scientists may have found a new way to help treat vascular dementia. ahmet rauf Ozkul/Getty Images Researchers have discovered a new way that brain blood flow problems are connected to a particular type of dementia called vascular dementia. They found that a protein called Piezo1 stops working properly due to the loss of a certain […]

Restoring missing lipid may help ease dementia damage in brain, study finds Read More »

Immune response to Epstein-Barr virus linked to brain damage in multiple sclerosis

January 13, 2026 / Research update / InnovateMed Author / multiple sclerosis

by Karolinska Institutet edited by Stephanie Baum, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source This electron microscopic image of two Epstein Barr Virus virions (viral particles) shows round capsids—protein-encased genetic material—loosely surrounded by the membrane envelope. Credit: PloS Biology (2005), DOI: 10.1371/journal.pbio.0030430.g001 The immune system’s reaction to the common Epstein-Barr virus can ultimately damage the

Immune response to Epstein-Barr virus linked to brain damage in multiple sclerosis Read More »

When smell is lost, our sense of touch may replace it

January 13, 2026 / Research update / InnovateMed Author / sense of touch

By Chelsea Haney January 12, 2026 Facebook Twitter LinkedIn Reddit Flipboard Email If we lose one sense maybe we can retrain other sensory pathways to pick up the lost information? Depositphotos View 1 Images For millions of people, losing their sense of smell quietly reshapes daily life. Meals lose nuance, familiar places feel strangely distant, and

When smell is lost, our sense of touch may replace it Read More »

Fat surrounding the colon interacts with the immune system, findings suggest

January 13, 2026 / Research update / InnovateMed Author / immune system

by Karolinska Institutet edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: CC0 Public Domain Abdominal fat is not a uniform tissue. A new study from Karolinska Institutet, Steno Diabetes Center Copenhagen, and Helmholtz Munich reveals that fat located close to the large intestine contains an unusually high number of

Fat surrounding the colon interacts with the immune system, findings suggest Read More »

Simple tool predicts who is most at risk of dementia after stroke

January 13, 2026 / Research update / InnovateMed Author / dementia

by University of New South Wales edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain A new international study led by researchers from UNSW Sydney’s Center for Healthy Brain Aging (CHeBA) has developed the first practical, five-year dementia risk prediction tool for stroke survivors—using only information that’s

Simple tool predicts who is most at risk of dementia after stroke Read More »

Stem cell expert Q&A: Innovative pathways in biomedical research

January 13, 2026 / Research update, stem cell therapy / InnovateMed Author / stem cell

by Cedars-Sinai Medical Center edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Clive Svendsen, Ph.D., with an organ-chip that replicates conditions cells would experience in an actual organ and is one of several new research methodologies. Credit: Cedars-Sinai Medical Center New scientific methods could one day render animal studies—the standard

Stem cell expert Q&A: Innovative pathways in biomedical research Read More »

Trial finds Zanidatamab + chemo beneficial in HER2-positive gastroesophageal cancer

January 13, 2026 / Research update / InnovateMed Author / gastroesphageal cancer

by Elana Gotkine edited by Stephanie Baum, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source For patients with human epidermal growth factor receptor 2-positive (HER2-positive) metastatic or locally advanced unresected gastroesophageal adenocarcinoma (mGEA), zanidatamab and chemotherapy, with or without tislelizumab, may prolong survival compared with trastuzumab + chemotherapy, according to a study presented

Trial finds Zanidatamab + chemo beneficial in HER2-positive gastroesophageal cancer Read More »

Two wrongs make a right: How two damaging disease variants can restore health

January 13, 2026 / Research update / InnovateMed Author / disease variant

by Pacific Northwest Research Institute edited by Stephanie Baum, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain Scientists at Pacific Northwest Research Institute (PNRI) have overturned a long-held belief in genetics: that inheriting two harmful variants of the same gene always worsens disease. Instead, the team found that in many

Two wrongs make a right: How two damaging disease variants can restore health Read More »

Depression may be an early warning sign of Parkinson’s disease and Lewy body dementia

January 13, 2026 / Research update / InnovateMed Author / depression

Peer-Reviewed Publication Shanghai Jiao Tong University Journal Center image: Hazard rate of incident depression preceding and following diagnosis of Parkinson’s disease, Lewy body dementia, rheumatoid arthritis, chronic kidney disease and osteoporosis. ‘0’ represents the date of diagnosis of Parkinson’s disease, Lewy body dementia, rheumatoid arthritis, chronic kidney disease and osteoporosis. view more Credit: Christopher Rohde, Martin Langeskov-Christensen, Lene

Depression may be an early warning sign of Parkinson’s disease and Lewy body dementia Read More »

New combination therapy for frequent form of lung cancer

January 13, 2026 / Research update / InnovateMed Author / lung cancer

Study identifies weak point in cancer cells as therapeutic perspective Peer-Reviewed Publication Medical University of Vienna A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer. The study shows that a combination of two well-studied classes of drugs – ERBB

New combination therapy for frequent form of lung cancer Read More »